Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer

Neoadjuvant chemotherapy has practical and theoretical advantages over adjuvant chemotherapy strategy in breast cancer (BC) management. Moreover, metronomic delivery has a more favorable toxicity profile. The present study examined the feasibility of neoadjuvant metronomic chemotherapy in two cohort...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Braz J Med Biol Res
Autors principals: Petry, V., Gagliato, D.M., Leal, A.I.C., Arai, R.J., Longo, E., Andrade, F., Ricci, M.D., Piato, J.R., Barroso-Sousa, R., Hoff, P.M., Mano, M.S.
Format: Artigo
Idioma:Inglês
Publicat: Associação Brasileira de Divulgação Científica 2015
Matèries:
Clinical Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4445673/
https://ncbi.nlm.nih.gov/pubmed/25760024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/1414-431X20144354
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars